메뉴 건너뛰기




Volumn 2013, Issue , 2013, Pages

Synergistic effects of secretory phospholipase Afrom the venom of Agkistrodon piscivorus piscivorus with cancer chemotherapeutic agents

Author keywords

[No Author keywords available]

Indexed keywords

1,6 DIPHENYL 1,3,5 HEXATRIENE; DACTINOMYCIN; DAUNORUBICIN; MEROCYANINE; METHOTREXATE; PACLITAXEL; PHOSPHOLIPASE A2; SNAKE VENOM; TRIMETHYLAMMONIUM SALT DERIVATIVE; ANTINEOPLASTIC AGENT; SECRETORY PHOSPHOLIPASE A2;

EID: 84874601783     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/565287     Document Type: Article
Times cited : (8)

References (31)
  • 1
    • 0021723288 scopus 로고
    • 2 with lysine in place of aspartate 49. Functional consequences for calcium and substrate binding
    • 2 with lysine in place of aspartate 49. Functional consequences for calcium and substrate binding. Journal of Biological Chemistry 1984 259 22 13839 13843 2-s2.0-0021723288 (Pubitemid 15222813)
    • (1984) Journal of Biological Chemistry , vol.259 , Issue.22 , pp. 13839-13843
    • Maraganore, J.M.1    Merutka, G.2    Cho, W.3
  • 3
    • 67649386799 scopus 로고    scopus 로고
    • Sequence of physical changes to the cell membrane during glucocorticoid-induced apoptosis in S49 lymphoma cells
    • 2-s2.0-67649386799 10.1016/j.bpj.2008.12.3925
    • Bailey R. W., Nguyen T., Robertson L., Gibbons E., Nelson J., Christensen R. E., Bell J. P., Judd A. M., Bell J. D., Sequence of physical changes to the cell membrane during glucocorticoid-induced apoptosis in S49 lymphoma cells. Biophysical Journal 2009 96 7 2709 2718 2-s2.0-67649386799 10.1016/j.bpj.2008. 12.3925
    • (2009) Biophysical Journal , vol.96 , Issue.7 , pp. 2709-2718
    • Bailey, R.W.1    Nguyen, T.2    Robertson, L.3    Gibbons, E.4    Nelson, J.5    Christensen, R.E.6    Bell, J.P.7    Judd, A.M.8    Bell, J.D.9
  • 5
    • 0027461154 scopus 로고
    • Use of merocyanine (MC540) in quantifying lipid domains and packing in phospholipid vesicles and tumor cells
    • DOI 10.1016/0005-2736(93)90348-4
    • Stillwell W., Wassall S. R., Dumaual A. C., Ehringer W. D., Browning C. W., Jenski L. J., Use of merocyanine (MC540) in quantifying lipid domains and packing in phospholipid vesicles and tumor cells. Biochimica et Biophysica Acta 1993 1146 1 136 144 2-s2.0-0027461154 10.1016/0005-2736(93)90348-4 (Pubitemid 23067052)
    • (1993) Biochimica et Biophysica Acta - Biomembranes , vol.1146 , Issue.1 , pp. 136-144
    • Stillwell, W.1    Wassall, S.R.2    Dumaual, A.C.3    Ehringer, W.D.4    Browning, C.W.5    Jenski, L.J.6
  • 6
    • 0021113818 scopus 로고
    • Merocyanine 540, a fluorescent probe sensitive to lipid packing
    • 2-s2.0-0021113818
    • Williamson P., Mattocks K., Schlegel R. A., Merocyanine 540, a fluorescent probe sensitive to lipid packing. BBA-Biomembranes 1983 732 2 387 393 2-s2.0-0021113818
    • (1983) BBA - Biomembranes , vol.732 , Issue.2 , pp. 387-393
    • Williamson, P.1    Mattocks, K.2    Schlegel, R.A.3
  • 15
    • 23944510494 scopus 로고    scopus 로고
    • Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines
    • DOI 10.1007/s00011-005-1355-8
    • Herman S., Zurgil N., Deutsch M., Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines. Inflammation Research 2005 54 7 273 280 2-s2.0-23944510494 10.1007/s00011-005-1355-8 (Pubitemid 41185488)
    • (2005) Inflammation Research , vol.54 , Issue.7 , pp. 273-280
    • Herman, S.1    Zurgil, N.2    Deutsch, M.3
  • 16
    • 0037446263 scopus 로고    scopus 로고
    • 1H NMR visible mobile lipids during apoptosis of paclitaxel-treated K562 cells
    • DOI 10.1016/S0006-2952(03)00080-7
    • Brisdelli F., Iorio E., Knijn A., Ferretti A., Marcheggiani D., Lenti L., Strom R., Podo F., Bozzi A., Two-step formation of 1H NMR visible mobile lipids during apoptosis of paclitaxel-treated K562 cells. Biochemical Pharmacology 2003 65 8 1271 1280 2-s2.0-0037446263 10.1016/S0006-2952(03)00080-7 (Pubitemid 36407779)
    • (2003) Biochemical Pharmacology , vol.65 , Issue.8 , pp. 1271-1280
    • Brisdelli, F.1    Iorio, E.2    Knijn, A.3    Ferretti, A.4    Marcheggiani, D.5    Lenti, L.6    Strom, R.7    Podo, F.8    Bozzi, A.9
  • 17
    • 0032029765 scopus 로고    scopus 로고
    • Regulatory effect of CD9 on calcium-stimulated phosphatidylserine exposure in Jurkat T lymphocytes
    • DOI 10.1006/abbi.1997.0535
    • Li W., Tait J. F., Regulatory effect of CD9 on calcium-stimulated phosphatidylserine exposure in Jurkat T lymphocytes. Archives of Biochemistry and Biophysics 1998 351 1 89 95 2-s2.0-0032029765 10.1006/abbi.1997.0535 (Pubitemid 28373055)
    • (1998) Archives of Biochemistry and Biophysics , vol.351 , Issue.1 , pp. 89-95
    • Li, W.1    Tait, J.F.2
  • 19
    • 67349173178 scopus 로고    scopus 로고
    • Snake venom inhibits the growth of mouse mammary tumor cells in vitro and in vivo
    • 2-s2.0-67349173178 10.1016/j.toxicon.2009.03.017
    • El-Refael M. F., Sarkar N. H., Snake venom inhibits the growth of mouse mammary tumor cells in vitro and in vivo. Toxicon 2009 54 1 33 41 2-s2.0-67349173178 10.1016/j.toxicon.2009.03.017
    • (2009) Toxicon , vol.54 , Issue.1 , pp. 33-41
    • El-Refael, M.F.1    Sarkar, N.H.2
  • 26
    • 61349123574 scopus 로고    scopus 로고
    • 2 as a prognostic marker in prostate cancer: Relevance to clinicopathological variables and disease-specific mortality
    • 2-s2.0-61349123574 10.1111/j.1600-0463.2008.00002.x
    • 2 as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality. APMIS 2009 117 3 151 161 2-s2.0-61349123574 10.1111/j.1600-0463.2008.00002.x
    • (2009) APMIS , vol.117 , Issue.3 , pp. 151-161
    • Mirtti, T.1    Laine, V.J.O.2    Hiekkanen, H.3    Hurme, S.4    Rowe, O.5    Nevalainen, T.J.6    Kallajoki, M.7    Alanen, K.8
  • 29
    • 0037201946 scopus 로고    scopus 로고
    • Biophysical mechanisms of phospholipase A2 activation and their use in liposome-based drug delivery
    • DOI 10.1016/S0014-5793(02)03408-7, PII S0014579302034087
    • 2 activation and their use in liposome-based drug delivery. FEBS Letters 2002 531 1 23 27 2-s2.0-0037201946 10.1016/S0014-5793(02) 03408-7 (Pubitemid 35232779)
    • (2002) FEBS Letters , vol.531 , Issue.1 , pp. 23-27
    • Jorgensen, K.1    Davidsen, J.2    Mouritsen, O.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.